{"id":"W2532432536","doi":"10.1177/1756283x16674660","title":"Everolimus in the management of metastatic neuroendocrine tumours","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Everolimus; Medicine; Pasireotide; Neuroendocrine tumors; PI3K/AKT/mTOR pathway; Temsirolimus; Oncology; Sirolimus; Internal medicine; Lanreotide; Targeted therapy; Cancer; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000400716,0.0006179288,0.002536512,0.0007704163,0.00002535921,0.000008315429,0.0009840566,0.00001534009,0.00008874018],"category_scores_gemma":[0.00003131837,0.0003502863,0.0003946272,0.0006089017,0.0004967269,0.0001721229,0.0002303258,0.0008706058,0.00003535347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000147394,"about_ca_system_score_gemma":0.00006846433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004054099,"about_ca_topic_score_gemma":0.00004149387,"domain_scores_codex":[0.9949852,0.001192129,0.00133852,0.0007265016,0.0005918172,0.001165868],"domain_scores_gemma":[0.9977875,0.0005431228,0.0005341755,0.0009985233,0.00004000211,0.00009671532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009274464,0.0005877216,0.001211466,0.01865627,0.0002571953,0.01367643,0.00002389986,0.000007671104,0.000001011731,0.000660694,0.00001395705,0.9639763],"study_design_scores_gemma":[0.004451363,0.002684236,0.0007229252,0.01494798,0.0008705397,0.01239427,0.000159574,0.000003886975,0.000003319476,0.001733361,0.961787,0.0002415252],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005346444,0.9953908,0.0001177777,0.0005641626,0.0002314491,0.002521617,0.00003041718,0.00002685728,0.0005822219],"genre_scores_gemma":[0.005685837,0.9924179,0.000449285,0.0004741792,0.00005141884,0.000672636,0.00001928971,0.00008339623,0.0001460288],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9637347,"threshold_uncertainty_score":0.9998949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04827955660449404,"score_gpt":0.4019686366715154,"score_spread":0.3536890800670214,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}